ASSET | DATE | % RETURN |
---|---|---|
Precision Optics Corporation, Inc Common stock (POCI) | 12/18/2008 - 12/28/2008 | 300% |
Sonoma Pharmaceuticals (SNOA) | 12/18/2008 - 12/28/2008 | 200.06% |
Lixte Biotechnology (LIXT) | 12/18/2008 - 12/28/2008 | 190% |
Chromadex (CDXC) | 12/18/2008 - 12/28/2008 | 160% |
TG Therapeutics (TGTX) | 12/18/2008 - 12/28/2008 | 100% |
Entravision Communications (EVC) | 12/18/2008 - 12/28/2008 | 98.58% |
Byrna Technologies (BYRN) | 12/18/2008 - 12/28/2008 | 93.75% |
Harrow Health (HROW) | 12/18/2008 - 12/28/2008 | 81.82% |
BlueLinx (BXC) | 12/18/2008 - 12/28/2008 | 78.05% |
Lithium Americas (Argentina) (LAAC) | 12/18/2008 - 12/28/2008 | 77.76% |
Marker Therapeutics (MRKR) | 12/18/2008 - 12/28/2008 | 75% |
Primo Brands (PRMB) | 12/18/2008 - 12/28/2008 | 60% |
Asia Pacific Wire & Cable (APWC) | 12/18/2008 - 12/28/2008 | 51.32% |
Firefly Neuroscience (AIFF) | 12/18/2008 - 12/28/2008 | 50% |
Anixa Biosciences (ANIX) | 12/18/2008 - 12/28/2008 | 47.34% |
Altimmune (ALT) | 12/18/2008 - 12/28/2008 | 45.52% |
Cyclacel Pharmaceuticals (CYCC) | 12/18/2008 - 12/28/2008 | 45.16% |
Cyclo Therapeutics (CYTH) | 12/18/2008 - 12/28/2008 | 45% |
Enveric Biosciences (ENVB) | 12/18/2008 - 12/28/2008 | 41.67% |
FitLife Brands, Inc Common Stock (FTLF) | 12/18/2008 - 12/28/2008 | 41.18% |
Avalon (AWX) | 12/18/2008 - 12/28/2008 | 40.37% |
Fennec Pharmaceuticals (FENC) | 12/18/2008 - 12/28/2008 | 40.35% |
ProPhase Labs (PRPH) | 12/18/2008 - 12/28/2008 | 38.66% |
Molecular Templates (MTEM) | 12/18/2008 - 12/28/2008 | 38.46% |
Ageagle Aerial Systems (UAVS) | 12/18/2008 - 12/28/2008 | 36.55% |